KV Pharmaceutical's Launch of Gestiva(TM) Delayed
...n. 26 /PRNewswire-FirstCall/ -- KV Pharmaceutical (NYSE: KVa/KVb) has been notified that the pending New Drug Application (NDA) for Gestiva(TM) (alpha hydroxyprogesterone caproate) will not be approved by the U.S. Food and Drug Administration (FDA) until further conditions are met. As previously disclosed, KV Pha...Drug Therapy can Reduce Preterm Births and Decrease Lifetime Medical Costs
...ase Western Reserve University in Cleveland, OH found that treating expectant mothers// who have had previous spontaneous preterm births with 17 Alpha hydroxyprogesterone caproate (17P) and reducing the incidence of another preterm birth would consequently reduce both short-term and lifetime medical costs in offspring b...17-OH Progesterone EIA Reproductive Markers 020-DR-1292 Reproductive Hormones
Description:... The steroid 17a hydroxyprogesterone (17aOHP) is produced by both the adrenal cortex and gonads. Even though 17aOHP has relatively little progestational activity, it is of intense clini...